0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-10-01 Sage Accounts Production Advanced 2024 - FRS102_2024 83 342 6,670 6,670 xbrli:pure xbrli:shares iso4217:GBP 12400537 2023-10-01 2024-09-30 12400537 2024-09-30 12400537 2023-09-30 12400537 2022-10-01 2023-09-30 12400537 2023-09-30 12400537 2022-09-30 12400537 core:PatentsTrademarksLicencesConcessionsSimilar 2023-10-01 2024-09-30 12400537 bus:RegisteredOffice 2023-10-01 2024-09-30 12400537 bus:LeadAgentIfApplicable 2023-10-01 2024-09-30 12400537 bus:Director1 2023-10-01 2024-09-30 12400537 core:PatentsTrademarksLicencesConcessionsSimilar 2024-09-30 12400537 core:WithinOneYear 2024-09-30 12400537 core:WithinOneYear 2023-09-30 12400537 core:RetainedEarningsAccumulatedLosses 2023-09-30 12400537 core:RetainedEarningsAccumulatedLosses 2022-09-30 12400537 core:RetainedEarningsAccumulatedLosses 2024-09-30 12400537 core:RetainedEarningsAccumulatedLosses 2023-09-30 12400537 core:ShareCapital 2024-09-30 12400537 core:ShareCapital 2023-09-30 12400537 bus:SmallEntities 2023-10-01 2024-09-30 12400537 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 12400537 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 12400537 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 12400537 bus:FullAccounts 2023-10-01 2024-09-30
COMPANY REGISTRATION NUMBER: 12400537
DNAFUEL Limited
Unaudited Financial Statements
30 September 2024
DNAFUEL Limited
Financial Statements
Year ended 30 September 2024
Contents
Page
Director's report
1
Chartered accountants report to the director on the preparation of the unaudited statutory financial statements
2
Statement of income and retained earnings
3
Statement of financial position
4
Notes to the financial statements
5
DNAFUEL Limited
Director's Report
Year ended 30 September 2024
The director presents his report and the unaudited financial statements of the company for the year ended 30 September 2024 .
Director
The director who served the company during the year was as follows:
Mr R Bagg
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 18 February 2025 and signed on behalf of the board by:
Mr R Bagg
Director
Registered office:
Delves Road
Heanorgate Industrial Estate
Heanor
Derbyshire
DE75 7SJ
DNAFUEL Limited
Chartered Accountants Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of DNAFUEL Limited
Year ended 30 September 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of DNAFUEL Limited for the year ended 30 September 2024, which comprise the statement of income and retained earnings, statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/membership/regulations-standards-and-guidance. This report is made solely to the director of DNAFUEL Limited. Our work has been undertaken solely to prepare for your approval the financial statements of DNAFUEL Limited and state those matters that we have agreed to state to you in this report in accordance with ICAEW Technical Release 07/16 AAF as detailed at www.icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than DNAFUEL Limited and its director for our work or for this report.
It is your duty to ensure that DNAFUEL Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of DNAFUEL Limited. You consider that DNAFUEL Limited is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the financial statements of DNAFUEL Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
GREGORY PRIESTLEY & STEWART Chartered Accountants
Lyndhurst 1-3 Cranmer Street Long Eaton Nottingham NG10 1NJ
18 February 2025
DNAFUEL Limited
Statement of Income and Retained Earnings
Year ended 30 September 2024
2024
2023
Note
£
£
Administrative expenses
83
342
----
----
Operating loss
( 83)
( 342)
----
----
Loss before taxation
( 83)
( 342)
Tax on loss
----
----
Loss for the financial year and total comprehensive income
( 83)
( 342)
----
----
Retained losses at the start of the year
( 897,450)
( 897,108)
---------
---------
Retained losses at the end of the year
( 897,533)
( 897,450)
---------
---------
All the activities of the company are from continuing operations.
DNAFUEL Limited
Statement of Financial Position
30 September 2024
2024
2023
Note
£
£
£
Current assets
Cash at bank and in hand
2,358
Creditors: amounts falling due within one year
5
897,433
899,708
---------
---------
Net current liabilities
897,433
897,350
---------
---------
Total assets less current liabilities
( 897,433)
( 897,350)
---------
---------
Capital and reserves
Called up share capital
100
100
Profit and loss account
( 897,533)
( 897,450)
---------
---------
Shareholders deficit
( 897,433)
( 897,350)
---------
---------
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 18 February 2025 , and are signed on behalf of the board by:
Mr R Bagg
Director
Company registration number: 12400537
DNAFUEL Limited
Notes to the Financial Statements
Year ended 30 September 2024
1. General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Delves Road, Heanorgate Industrial Estate, Heanor, Derbyshire, DE75 7SJ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities measured at fair value through profit or loss. The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
Due to the severe lack of sales the company was able to generate the company's director took the decision to cease the company's operations. The company's fixed asset values were therefore considered to be impaired last year and as a result reduced in the accounts to their estimated amounts recoverable assuming they were disposed in a fire sale. The company relied on financing from its parent company R Bagg Limited and the partial repayment of this loan will only be made from cash available after settling all other liabilities.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Patents, trademarks and licences
-
20% straight line
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.
4. Intangible assets
Patents, trademarks and licences
£
Cost
At 1 October 2023 and 30 September 2024
6,670
-------
Amortisation
At 1 October 2023 and 30 September 2024
6,670
-------
Carrying amount
At 30 September 2024
-------
At 30 September 2023
-------
5. Creditors: amounts falling due within one year
2024
2023
£
£
Amounts owed to group undertakings and undertakings in which the company has a participating interest
897,433
899,708
---------
---------